FIBRORESTIL®
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FIBRORESTIL®, covering 2026-01-14 to 2026-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Pilot Study on the Efficacy and Safety of FIBRORESTIL® as an Adjuvant Intralesional Treatment in Patients With Peyronie's Disease Receiving Standard Therapy [NA]